A U.S. company may offer more to its principals than access to customers and capital. If an entrepreneur receives qualified small business stock (QSBS) in an eligible U.S. corporation, federal law may exclude a substantial portion of the gain when those shares are sold. But the value of that exclusion differs sharply for a founder who becomes a U.S. income-tax resident and one who remains a U.S. nonresident.
For qualifying stock acquired after 4 July 2025, a noncorporate taxpayer may exclude 50 percent of eligible gain after at least three years, 75 percent after at least four years, and 100 percent after at least five years. Generally, the gain eligible for exclusion from one issuer is limited to the greater of (x) $15 million (subject to specified adjustments) and (y) 10 times the taxpayer’s adjusted basis in the QSBS sold.
To qualify as QSBS, the shares generally must be issued by a domestic C corporation, acquired directly for cash, eligible property or services, and held while the corporation meets certain active-business requirements. The corporation’s aggregate gross assets generally may not exceed $75 million before and immediately after issuance of the shares, including the proceeds raised. At least 80 percent of the assets (by value) must generally be used in an active qualified business during substantially all of the shareholder’s holding period. Several activities—including consulting, financial services, leasing and operating a hotel or restaurant—are excluded; significant passive real estate can also prevent QSBS qualification.
A founder who becomes a U.S. tax resident generally becomes taxable by the United States on the founder’s worldwide income: a sale of appreciated U.S. company shares can therefore produce a U.S. federal tax liability even if the shares were purchased while the founder lived abroad. QSBS status can be particularly valuable in this scenario: the qualifying exclusion may remove some or all of otherwise taxable gain from federal gross income, within the statutory limits.
A U.S. exclusion does not affect any continuing tax consequences in the founder’s former country.. State income tax results must likewise be checked where the founder becomes resident.
For a founder who remains a U.S. nonresident alien, gain from selling ordinary corporate stock is often outside U.S. federal income tax even without QSBS benefits. Thus, the regime may provide less immediate U.S. tax benefit to a founder who sells QSBS while not a U.S. resident.
Nevertheless, in some cases qualification under the QSBS rules may provide a benefit even to a nonresident. Gains on dispositions of shares in U.S. real property holding corporations, or attributable to a U.S. office or effectively connected with a U.S. business, can attract U.S. capital gains tax that can be mitigated if the QSBS benefits are available.
A foreign founder considering a U.S. expansion should settle the ownership structure and document QSBS eligibility before the initial issuance of shares in a U.S. entity. QSBS treatment will often be most beneficial for a founder who will be a U.S. taxpayer when the shares are sold: for a founder remaining abroad, the gating question will be whether the United States would tax the stock gain even in the absence of a QSBS election. Early, coordinated U.S. and home-country tax planning can preserve options that may no longer be available on the eve of an exit.
This web site contains attorney advertising.
© 2026 Andersen Law LLC | Communications Policy | Artificial Intelligence Policy | Privacy Policies | Terms
Law Firm Website Design by The Modern Firm